D. Campbell

发表

Circulating and tissue angiotensin systems.

D. Campbell, D. Campbell, 1987, The Journal of clinical investigation.

Noninvasive Cardiac Imaging and the Prediction of Heart Failure Progression in Preclinical Stage A/B Subjects.

D. Campbell, D. Prior, F. Gong, 2017, JACC. Cardiovascular imaging.

Activation of the kallikrein-kinin system by cardiopulmonary bypass in humans.

B. Dixon, D. Campbell, J. Santamaria, 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

Early identification of asymptomatic subjects at increased risk of heart failure and cardiovascular events: progress and future directions.

H. Krum, D. Campbell, D. Prior, 2013, Heart, lung & circulation.

Neprilysin Inhibitors and Bradykinin

D. Campbell, D. Campbell, 2018, Front. Med..

Bradykinin peptides in kidney, blood, and other tissues of the rat.

D. Campbell, A. Kladis, A. Duncan, 1993, Hypertension.

Sympathetic Augmentation in Hypertension: Role of Nerve Firing, Norepinephrine Reuptake, and Angiotensin Neuromodulation

M. Esler, D. Kaye, D. Campbell, 2004, Hypertension.

Myocardial Uptake and Biochemical and Hemodynamic Effects of ACE Inhibitors in Humans

J. Horowitz, D. Campbell, C. Zeitz, 2003, Hypertension.

AMP-activated protein kinase is not down-regulated in human skeletal muscle of obese females.

G. Heigenhauser, B. Kemp, S. Murthy, 2004, The Journal of clinical endocrinology and metabolism.

The Peripheral Renin–Angiotensin System Is Not Involved In The Hypertension Of Sheep Exposed To Prenatal Dexamethasone

E. Wintour, M. Dodic, D. Campbell, 2001, Clinical and experimental pharmacology & physiology.

Increased Angiotensin II–Induced Hypertension and Inflammatory Cytokines in Mice Lacking Angiotensin-Converting Enzyme N Domain Activity

K. Bernstein, D. Campbell, Kandarp H. Shah, 2012, Hypertension.

The Kallikrein–Kinin System In Humans

D. Campbell, D. Campbell, 2001, Clinical and experimental pharmacology & physiology.

The renin-angiotensin and the kallikrein-kinin systems.

D. Campbell, D. Campbell, 2003, The international journal of biochemistry & cell biology.

Plasma amino‐terminal pro‐brain natriuretic peptide levels in subjects presenting to the Emergency Department with suspected acute coronary syndrome: possible role in selecting patients for follow up?

D. Campbell, A. Dent, O. Hennessy, 2001, Internal medicine journal.

Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension.

H. Krum, M. Esler, D. Campbell, 2006, American journal of physiology. Heart and circulatory physiology.

How should I combine β-blockers, ACE inhibitors and ARBs in the management of heart failure?

D. Campbell, 2003 .

Angiotensin vaccination: What is the prospect of success?

D. Campbell, 2009, Current hypertension reports.

Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction.

D. Campbell, L. Burrell, A. Kladis, 1996, Journal of cardiovascular pharmacology.

Angiotensin-Converting Enzyme C-Terminal Catalytic Domain Is the Main Site of Angiotensin I Cleavage In Vivo

M. Capecchi, P. Corvol, K. Bernstein, 2008, Hypertension.

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS AND KININ METABOLISM: EVIDENCE THAT ACE INHIBITORS MAY INHIBIT A KININASE OTHER THAN ACE

D. Campbell, 1995, Clinical and experimental pharmacology & physiology.

Diastolic Dysfunction of Aging Is Independent of Myocardial Structure but Associated with Plasma Advanced Glycation End-Product Levels

A. Jenkins, C. Schalkwijk, M. Black, 2012, PloS one.

Circulating and Tissue Angiotensin Systems

D. Campbell, D. Campbell, 1987 .

(Pro)renin Receptor: A Treatment Target for Diabetic Retinopathy?

J. L. Wilkinson‐Berka, D. Campbell, J. L. Wilkinson-Berka, 2009, Diabetes.

Hypertension in the (mRen-2)27 Rat Is Not Explained by Enhanced Kinetics of Transgenic Ren-2 Renin

D. Campbell, S. Skinner, P. Rong, 2003, Hypertension.

Angiotensin Peptides in Brain and Pituitary of Rat and Sheep

D. Campbell, L. Clarke, A. Lawrence, 1992, Journal of neuroendocrinology.

Effects of Losartan on Angiotensin and Bradykinin Peptides and Angiotensin‐Converting Enzyme

D. Campbell, A. Valentijn, A. Kladis, 1995, Journal of cardiovascular pharmacology.

Nephrectomy, converting enzyme inhibition, and angiotensin peptides.

D. Campbell, A. Kladis, A. Duncan, 1993, Hypertension.

Angiotensin and bradykinin peptides in rats with myocardial infarction.

D. Campbell, L. Burrell, A. Kladis, 1997, Journal of cardiac failure.

GENETIC MODELS PROVIDE UNIQUE INSIGHT INTO ANGIOTENSIN AND BRADYKININ PEPTIDES IN THE EXTRAVASCULAR COMPARTMENT OF THE HEART IN VIVO

K. Bernstein, D. Campbell, S. Fuchs, 2009, Clinical and experimental pharmacology & physiology.

Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.

D. Campbell, A. Kladis, A. Duncan, 1994, Hypertension.

Identification of vascular renin‐binding proteins by chemical cross‐linking: inhibition of binding of renin by renin inhibitors

D. Campbell, A. Valentijn, 1994, Journal of hypertension.

Angiotensin II and norepinephrine release: interaction and effects on the heart

M. Esler, D. Kaye, D. Campbell, 2005, Journal of hypertension.

Angiotensin-converting enzyme inhibition modifies angiotensin but not kinin peptide levels in human atrial tissue.

D. Campbell, A. Kladis, A. Duncan, 1999, Hypertension.

Angiotensin II generation in vivo: does it involve enzymes other than renin and angiotensin-converting enzyme?

D. Campbell, D. Campbell, 2012, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Angiotensin and bradykinin peptides in the TGR(mRen-2)27 rat.

D. Ganten, D. Campbell, S. Skinner, 1995, Hypertension.

Differential Regulation of Angiotensin Peptide Levels in Plasma and Kidney of the Rat

D. Campbell, A. Valentijn, A. Kladis, 1991, Hypertension.

Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement.

J. Ménard, A. Morganti, M. Stowasser, 2009, Clinical chemistry.

Clinical Relevance of Local Renin Angiotensin Systems

D. Campbell, D. Campbell, 2014, Front. Endocrinol..

Long-term neprilysin inhibition — implications for ARNIs

D. Campbell, D. Campbell, 2017, Nature Reviews Cardiology.

METABOLISM OF TETRADECAPEPTIDE, ANGIOTENSINOGEN AND ANGIOTENSIN I AND II BY ISOLATED PERFUSED RAT HINDLIMBS

D. Campbell, J. Ziogas, A. Kladis, 1990, Clinical and experimental pharmacology & physiology.

Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease.

M. Woodward, A. Jenkins, S. MacMahon, 2006, Archives of neurology.

Plasminogen activator inhibitor activity is associated with raised lactate levels after cardiac surgery with cardiopulmonary bypass*

B. Dixon, D. Campbell, J. Santamaria, 2003, Critical care medicine.

Associations of Inflammatory and Hemostatic Variables With the Risk of Recurrent Stroke

M. Woodward, G. Lowe, A. Rumley, 2005, Stroke.

Brain renin-angiotensin system: focus on transgenic animal models

N. Alenina, D. Campbell, Ovidiu Constantin Baltatu, 2006 .

Increased tissue kallikrein levels in type 2 diabetes

A. Jenkins, M. Black, D. Campbell, 2010, Diabetologia.

Aliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 rat

J. L. Wilkinson‐Berka, D. Campbell, K. McMaster, 2011, Diabetologia.

Age‐related longitudinal change in cardiac structure and function in adults at increased cardiovascular risk

C. Reid, S. Stewart, H. Krum, 2020, ESC heart failure.

Why do men and women differ in their risk of myocardial infarction?

D. Campbell, 2008, European heart journal.

Primary prevention of cardiovascular disease: new guidelines, technologies and therapies

D. Campbell, 2014, The Medical journal of Australia.

The Differential Effect of Apyrase Treatment and hCD39 Overexpression on Chronic Renal Fibrosis After Ischemia-Reperfusion Injury

J. Chia, D. Campbell, P. Cowan, 2017, Transplantation.

Losartan Increases Bradykinin Levels in Hypertensive Humans

H. Krum, M. Esler, D. Campbell, 2005, Circulation.

Genetic and dietary control of plasma tissue kallikrein secretion and urinary kinins exretion in man

M. Azizi, D. Campbell, C. Emanueli, 2008, Journal of hypertension.

Kinins in humans.

A. Dart, G. Jennings, M. Esler, 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

Heart Differences in Myocardial Structure and Coronary Microvasculature Between Men and Women With Coronary Artery Disease

A. Jenkins, M. Black, D. Campbell, 2011 .

Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide in individuals with cerebrovascular disease

M. Woodward, A. Jenkins, S. MacMahon, 2007, Journal of hypertension.

Angiotensin-converting enzyme determination in plasma during therapy with converting enzyme inhibitor: two methods compared.

D. Campbell, T. Gorski, D. Campbell, 1991, Clinical chemistry.

Angiotensin-(1--7) in the ovine fetus.

E. Wintour, D. Campbell, K. Moritz, 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: a randomized controlled trial

B. Dixon, M. Schultz, D. Campbell, 2010, Critical care.

Cellular localization of angiotensinogen gene expression in brown adipose tissue and mesentery: quantification of messenger ribonucleic acid abundance using hybridization in situ.

J. Habener, D. Campbell, Duncan J. Campbell, 1987, Endocrinology.

β-blockers, angiotensin II, and ACE inhibitors in patients with heart failure

M. Esler, D. Kaye, D. Campbell, 2001, The Lancet.

Renin‐angiotensin system inhibition: how much is too much of a good thing?

D. Campbell, D. J. Campbell, 2002, Internal medicine journal.

Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat.

J. Habener, D. Campbell, 1986, The Journal of clinical investigation.

beta-blockers, angiotensin II, and ACE inhibitors in patients with heart failure.

M. Esler, D. Kaye, D. Campbell, 2001, Lancet.

Is aldosterone secretion under dopaminergic control?

J. Funder, D. Campbell, W. Adam, 1981, Circulation research.

Therapeutic modulation of tissue kallikrein expression

D. Campbell, 2016, Biological chemistry.

Aliskiren Reduces Myocardial Ischemia–Reperfusion Injury by a Bradykinin B2 Receptor– and Angiotensin AT2 Receptor–Mediated Mechanism

D. Campbell, J. Ziogas, S. Koid, 2014, Hypertension.

L-NAME hypertension: trying to fit the pieces together.

D. Campbell, D. Campbell, 2006, Journal of hypertension.

Purification and amino‐terminal sequence of rat kidney renin: evidence for a two‐chain structure

D. Campbell, A. Valentijn, R. Condron, 1991, Journal of hypertension.

Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction.

K. Mitchelhill, D. Campbell, S. Schlicht, 2000, Journal of cardiac failure.

Proceedings of the Symposium ‘Angiotensin AT1 Receptors: From Molecular Physiology to Therapeutics’: ENDOGENOUS ANGIOTENSIN II LEVELS AND THE MECHANISM OF ACTION OF ANGIOTENSIN‐CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR TYPE 1 ANTAGONISTS

D. Campbell, 1996, Clinical and experimental pharmacology & physiology.

Simultaneous radioimmunoassay of six angiotensin peptides in arterial and venous plasma of man.

D. Campbell, A. Kladis, D. Campbell, 1990, Journal of hypertension.

Tissue Renin‐Angiotensin System: Sites of Angiotensin Formation

D. Campbell, 1987, Journal of cardiovascular pharmacology.

Mice expressing ACE only in the heart show that increased cardiac angiotensin II is not associated with cardiac hypertrophy.

K. Bernstein, D. Campbell, E. Bernstein, 2008, American journal of physiology. Heart and circulatory physiology.

Animal Model Mice with Cardiac-Restricted Angiotensin-Converting Enzyme (ACE) Have Atrial Enlargement, Cardiac Arrhythmia, and Sudden Death

M. Capecchi, H Zhao, B. Hoit, 2004 .

Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.

T. Briscoe, D. Campbell, A. Kladis, 1998, The Journal of pharmacology and experimental therapeutics.

Increased levels of bradykinin and its metabolites in tissues of young spontaneously hypertensive rats

D. Campbell, A. Kladis, A. Duncan, 1995, Journal of hypertension.

Characterization of precursor and secreted forms of rat angiotensinogen.

J. Ménard, F. Pinet, P. Corvol, 1984, Endocrinology.

Letter by Campbell Regarding Article, "Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects".

D. Campbell, 2016, Circulation.

Angiotensin peptides in spontaneously hypertensive and normotensive Donryu rats.

D. Campbell, A. Kladis, A. Duncan, 1995, Hypertension.

Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation

J. Horowitz, M. Esler, D. Campbell, 2004, Journal of hypertension.

Critical review of prorenin and (pro)renin receptor research.

D. Campbell, D. Campbell, 2008, Hypertension.

An alternative strategy for the radioimmunoassay of angiotensin peptides using amino-terminal-directed antisera: measurement of eight angiotensin peptides in human plasma.

G. Evin, D. Campbell, A. Kladis, 1990, Journal of hypertension.

Chapter 188 – Bradykinin Peptides

D. Campbell, 2013 .

Experimental and Clinical Pharmacology: Renin inhibitors - mechanisms of action

D. Campbell, D. Campbell, 2009 .

Bradykinin and Its Related Peptides

D. Campbell, 2006 .

AT1 receptor-activated signaling mediates angiotensin IV-induced renal cortical vasoconstriction in rats.

M. Ohishi, X. Li, J. Zhuo, 2006, American journal of physiology. Renal physiology.

Effect of Reduced Angiotensin-Converting Enzyme Gene Expression and Angiotensin-Converting Enzyme Inhibition on Angiotensin and Bradykinin Peptide Levels in Mice

P. Corvol, K. Bernstein, T. Alexiou, 2004, Hypertension.

Processing of rat and human angiotensinogen precursors by microsomal membranes

J. Ménard, P. Corvol, D. Campbell, 1985, Molecular and Cellular Endocrinology.

Developmental expression of the angiotensinogen gene in rat embryos.

J. Habener, D. Campbell, H. U. Lee, 1987, Endocrinology.

Identity of angiotensinogen precursors of rat brain and liver

J. Ménard, P. Corvol, D. Campbell, 1984, Nature.

Angiotensinogen and angiotensin-converting enzyme gene copy number and angiotensin and bradykinin peptide levels in mice

L. Walker, D. Denton, T. Alexiou, 2005, Journal of hypertension.

Chronic ethanol ingestion increases superoxide production and NADPH oxidase expression in the lung.

R. Clempus, C. Hart, D. Campbell, 2006, American journal of respiratory cell and molecular biology.

Hybridization in situ studies of angiotensinogen gene expression in rat adrenal and lung.

J. Habener, D. Campbell, D. Campbell, 1989, Endocrinology.

Effect of rat plasma lipoproteins on aldosterone production by rat zona glomerulosa cells in vitro.

D. Campbell, 1982, Journal of steroid biochemistry.

The site of angiotensin production.

D. Campbell, 1985, Journal of hypertension.

Coagulation activation and organ dysfunction following cardiac surgery.

B. Dixon, D. Campbell, J. Santamaria, 2005, Chest.

Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation.

S. Robson, H. Nandurkar, D. Campbell, 2004, The Journal of clinical investigation.

The effect of etanercept on lung leukocyte margination and fibrin deposition after cardiac surgery.

David A Scott, B. Dixon, K. Opeskin, 2013, American journal of respiratory and critical care medicine.

Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: a randomized controlled trial

B. Dixon, M. Schultz, D. Campbell, 2010, Critical care.

Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart

Davis J. McCarthy, Yuan Zhang, W. Shi, 2011, Clinical and experimental pharmacology & physiology.

Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides.

D. Campbell, D. Campbell, 2000, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

The operating surgeon is an independent predictor of chest tube drainage following cardiac surgery.

B. Dixon, D. Campbell, A. Newcomb, 2014, Journal of cardiothoracic and vascular anesthesia.

Risk Factors for Incident Heart Failure with Preserved or Reduced Ejection Fraction in a Community-Based Cohort

S. Stewart, R. Wolfe, H. Krum, 2018 .

Angiotensin Peptides in Plasma and Kidney 765 Extraction and Radioimmunoassay of Angiotensin Peptides From Rat Kidney

D. Campbell, A. Valentijn, A. Kladis, 2005 .

Interpretation of plasma renin concentration in patients receiving aliskiren therapy.

D. Campbell, D. Campbell, 2008, Hypertension.

Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.

T. Briscoe, D. Campbell, A. Kladis, 1999, The Journal of pharmacology and experimental therapeutics.

Converting Enzyme Inhibition and Its Withdrawal in Spontaneously Hypertensive Rats

S. Harrap, D. Campbell, A. Kladis, 1995, Journal of cardiovascular pharmacology.

Characterisation of a thymic renin–angiotensin system in the transgenic m(Ren-2)27 rat

D. Campbell, D. Kelly, S. Skinner, 2002, Molecular and Cellular Endocrinology.

Type 2 bradykinin-receptor antagonism does not modify kinin or angiotensin peptide levels.

T. Briscoe, J. Zhuo, D. Campbell, 1999, Hypertension.

Production of rat renin fusion protein in Escherichia coli and the preparation of renin-specific antisera

D. Campbell, A. Valentijn, J. Berka, 1990, Molecular and Cellular Endocrinology.

Prorenin Contributes to Angiotensin Peptide Formation in Transgenic Rats With Rat Prorenin Expression Targeted to the Liver

J. Ménard, J. Mullins, P. Bruneval, 2009, Hypertension.

RILLKKMPSV Influences the Vasculature, Neurons and Glia, and (Pro)Renin Receptor Expression in the Retina

M. Cooper, E. Fletcher, J. L. Wilkinson‐Berka, 2010, Hypertension.

SHEEP HYPOTHALAMUS CONTAINS A NON‐ANGIOTENSIN LIGAND FOR TYPE 1 AND TYPE 2 ANGIOTENSIN II RECEPTORS

D. Campbell, A. Kladis, I. Clarke, 1993, Clinical and experimental pharmacology & physiology.

Elevated pulmonary dead space and coagulation abnormalities suggest lung microvascular thrombosis in patients undergoing cardiac surgery

B. Dixon, D. Campbell, J. Santamaria, 2008, Intensive Care Medicine.

Increased dietary NaCl potentiates the effects of elevated prorenin levels on blood pressure and organ disease

J. Ménard, J. Mullins, P. Bruneval, 2010, Journal of hypertension.

Nebulized heparin reduces levels of pulmonary coagulation activation in acute lung injury

B. Dixon, J. Hofstra, M. Schultz, 2010, Critical care.

Angiotensin-(1-7) Enhances Anti-Aggregatory Effects of the Nitric Oxide Donor Sodium Nitroprusside

J. Horowitz, D. Campbell, S. Rajendran, 2005, Journal of cardiovascular pharmacology.

Characterization of angiotensin peptides in plasma of anephric man.

J. Whitworth, D. Campbell, S. Skinner, 1991, Journal of hypertension.

The association of blood transfusion with mortality after cardiac surgery: cause or confounding? (CME)

B. Dixon, D. Campbell, A. Newcomb, 2013, Transfusion.

Aprotinin, but not tranexamic acid, is associated with increased pulmonary microvascular fibrin deposition after cardiac surgery.

B. Silbert, B. Dixon, K. Opeskin, 2011, Thrombosis research.

Pre-operative heparin reduces pulmonary microvascular fibrin deposition following cardiac surgery.

B. Dixon, K. Opeskin, D. Campbell, 2011, Thrombosis research.

Prothrombin Fragment 1+2 Levels Are Associated with Pulmonary and Renal Responses to Cardiopulmonary Bypass

B. Dixon, D. Campbell, J. Santamaria, 2001 .

Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease.

M. Woodward, S. MacMahon, J. Chalmers, 2005, European heart journal.

Characterization of precursor and secreted forms of human angiotensinogen.

J. Ménard, P. Corvol, D. Campbell, 1985, The Journal of clinical investigation.

Osmoregulatory fluid intake but not hypovolemic thirst is intact in mice lacking angiotensin.

L. Walker, D. Denton, T. Alexiou, 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease

A. Jenkins, C. Schalkwijk, M. Black, 2011, Cardiovascular diabetology.

Immunccytochemical Localization of Angiotensinogen in Rat Brain: Dependence of Neuronal Immunoreactivity on Method of Tissue Processing

B. Oldfield, D. Campbell, C. Sernia, 1991, Journal of neuroendocrinology.

Prediction of incident heart failure by serum amino‐terminal pro‐B‐type natriuretic peptide level in a community‐based cohort

S. Stewart, R. Wolfe, H. Krum, 2019, European journal of heart failure.

AMPK beta subunit targets metabolic stress sensing to glycogen.

B. Kemp, M. Parker, S. Feil, 2003, Current biology : CB.

Clinical apnea and brain-stem neural function in preterm infants.

D. Henderson-smart, A. Pettigrew, D. Campbell, 1983, The New England journal of medicine.

Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

J. Moran, E. Broadfield, G. Doig, 2021, The Lancet Respiratory Medicine.

AMP-activated protein kinase, super metabolic regulator.

D J Campbell, B. Kemp, T. Iseli, 2001, Biochemical Society transactions.

Risk factor management in a contemporary Australian population at increased cardiovascular disease risk

R. Wolfe, H. Krum, D. Liew, 2018, Internal medicine journal.

Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death.

M. Capecchi, H Zhao, B. Hoit, 2004, The American journal of pathology.

[19] Strategies for measurement of angiotensin and bradykinin peptides and their metabolites in central nervous system and other tissues

D. Campbell, A. Kladis, A. Duncan, 1995 .

Can cardiovascular disease guidelines that advise treatment decisions based on absolute risk be improved?

D. Campbell, D. Campbell, 2016, BMC Cardiovascular Disorders.

Endogenous angiotensin II levels and the mechanism of action of angiotensin-converting enzyme inhibitors and angiotensin receptor type 1 antagonists.

D. Campbell, 1996, Clinical and experimental pharmacology & physiology. Supplement.

AMPK β Subunit Targets Metabolic Stress Sensing to Glycogen

B. Kemp, M. Parker, S. Feil, 2003, Current Biology.

Threshold body mass index and sex-specific waist circumference for increased risk of heart failure with preserved ejection fraction

C. Reid, S. Stewart, H. Krum, 2019, European journal of preventive cardiology.

Whole Body Deletion of AMP-activated Protein Kinase β2 Reduces Muscle AMPK Activity and Exercise Capacity*

B. Kemp, S. Jørgensen, J. Schertzer, 2010, The Journal of Biological Chemistry.

Intrarenal angiotensin and bradykinin peptide levels in the remnant kidney model of renal insufficiency.

T. Meyer, D. Campbell, F. Mackie, 2001, Kidney International.

ACE Inhibition in Heart Failure and Ischaemic Heart Disease

D. Campbell, D. Campbell, 2007, Frontiers in Research of the Renin-Angiotensin System on Human Disease.

Carvedilol reduces aldosterone release in systolic heart failure.

D. Campbell, A. Aggarwal, J. Wong, 2006, Heart, lung & circulation.

Differences in Myocardial Structure and Coronary Microvasculature Between Men and Women With Coronary Artery Disease

A. Jenkins, D. Campbell, A. Newcomb, 2011, Hypertension.

Putting blood pressure in its place.

D. Campbell, D. Campbell, 2007, Journal of hypertension.

A Review of Perindopril in the Reduction of Cardiovascular Events

D. Campbell, 2006, Vascular health and risk management.

Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats.

J. Ménard, M. Azizi, D. Campbell, 1997, Circulation.

Risk factors for asymptomatic echocardiographic abnormalities that predict symptomatic heart failure

H. Krum, D. Liew, D. Campbell, 2021, ESC heart failure.

Prediction of Myocardial Infarction by N-Terminal-Pro-B-Type Natriuretic Peptide, C-Reactive Protein, and Renin in Subjects With Cerebrovascular Disease

M. Woodward, A. Jenkins, S. MacMahon, 2005, Circulation.

Vasopeptidase Inhibition. A Double-Edged Sword?

D. Campbell, D. Campbell, 2003 .

A Double-Edged Sword?

D. Campbell, 2003 .

Age‐specific diastolic dysfunction improves prediction of symptomatic heart failure by Stage B heart failure

C. Reid, S. Stewart, H. Krum, 2019, ESC heart failure.

N‐terminal B‐type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: results of the SCReening Evaluation of the Evolution of New‐Heart Failure Study (SCREEN‐HF)

R. Wolfe, H. Krum, D. Liew, 2013, European journal of heart failure.

NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure study (SCREEN-HF).

C. Reid, S. Stewart, R. Wolfe, 2013, International journal of cardiology.

Heart failure: how can we prevent the epidemic?

D. Campbell, D. Campbell, 2004, The Medical journal of Australia.

Heart failure: how can we prevent the epidemic?

D. Campbell, D. Campbell, 2003 .

Kidney age - chronological age difference (KCD) score provides an age-adapted measure of kidney function

C. Reid, S. Stewart, H. Krum, 2021, BMC Nephrology.

Risk factors for incident heart failure with preserved or reduced ejection fraction, and valvular heart failure, in a community-based cohort

C. Reid, S. Stewart, R. Wolfe, 2018, Open Heart.

Most individuals with treated blood pressures above target receive only one or two antihypertensive drug classes

C. Reid, S. Stewart, R. Wolfe, 2013, Internal medicine journal.

Prediction of Heart Failure by Amino Terminal-pro–B-Type Natriuretic Peptide and C-Reactive Protein in Subjects With Cerebrovascular Disease

M. Woodward, A. Jenkins, S. MacMahon, 2005, Hypertension.

SCReening Evaluation of the Evolution of New Heart Failure Study (SCREEN-HF): early detection of chronic heart failure in the workplace.

C. Reid, S. Stewart, R. Wolfe, 2017, Australian health review : a publication of the Australian Hospital Association.

Do intravenous and subcutaneous angiotensin II increase blood pressure by different mechanisms?

D. Campbell, D. Campbell, 2013, Clinical and experimental pharmacology & physiology.

Adrenocorticotropin, β-Endorphin, and β-Mipotropin in Normal Thyroid and Lung: Possible Implications for Ectopic Hormone Secretion

J. Clements, M. Hearn, J. Funder, 1982 .

Changes in the relationship between cerebrospinal fluid and blood composition produced by ACTH treatment in conscious sheep.

D. Denton, R. Weisinger, D. Campbell, 1980, Life sciences.

Increased bradykinin levels accompany the hemodynamic response to acute inhibition of angiotensin-converting enzyme in dogs with heart failure.

F. Barbe, L. Hittinger, D. Campbell, 1999, Journal of cardiovascular pharmacology.

Long‐term renoprotection by perindopril or nifedipine in non‐hypertensive patients with Type 2 diabetes and microalbuminuria

C. Tsalamandris, G. Jerums, M. Cooper, 2004, Diabetic medicine : a journal of the British Diabetic Association.

Calibrated integrated backscatter and myocardial fibrosis in patients undergoing cardiac surgery

Alicia J Jenkins, A. Jenkins, C. Schalkwijk, 2015, Open Heart.

Marked difference between angiotensin-converting enzyme and neutral endopeptidase inhibition in vivo by a dual inhibitor of both enzymes.

T. Briscoe, D. Campbell, A. Kladis, 1998, The Journal of pharmacology and experimental therapeutics.

Prorenin stimulates a pro‐angiogenic and pro‐inflammatory response in retinal endothelial cells and an M1 phenotype in retinal microglia

A. Agrotis, D. Campbell, D. Deliyanti, 2015, Clinical and experimental pharmacology & physiology.

Obesity Is Associated with Lower Coronary Microvascular Density

M. Black, D. Campbell, A. Newcomb, 2013, PloS one.

Increased bradykinin and "normal" angiotensin peptide levels in diabetic Sprague-Dawley and transgenic (mRen-2)27 rats.

M. Cooper, D. Campbell, D. Kelly, 1999, Kidney international.

Metoclopramide does not elevate aldosterone in the rat.

J. Funder, D. Campbell, W. Adam, 1981, Endocrinology.

A phase 1 trial of nebulised heparin in acute lung injury

B. Dixon, D. Campbell, J. Santamaria, 2008, Critical care.

CAN MEASUREMENT OF B‐TYPE NATRIURETIC PEPTIDE LEVELS IMPROVE CARDIOVASCULAR DISEASE PREVENTION?

D. Campbell, D. Campbell, 2008, Clinical and experimental pharmacology & physiology.

Prediction of cardiovascular death and non-fatal cardiovascular events by the Kidney age–Chronological age Difference (KCD) score in men and women of different ages in a community-based cohort

D. Magliano, D. Campbell, J. Shaw, 2023, BMJ open.

The clinical utility curve: a proposal to improve the translation of information provided by prediction models to clinicians

D. Campbell, D. Campbell, 2016, BMC Research Notes.

The clinical utility curve: a proposal to improve the translation of information provided by prediction models to clinicians

D. Campbell, 2016, BMC Research Notes.

Cellophane Perinephritis Hypertension and Its Reversal in Rabbits: Effect on Plasma Renin, Renin Substrate, and Renal Mass

A. J. Day, D. Campbell, S. Skinner, 1973, Circulation research.

AMPK β1 Deletion Reduces Appetite, Preventing Obesity and Hepatic Insulin Resistance*

A. Hevener, B. Kemp, S. Jørgensen, 2009, The Journal of Biological Chemistry.

Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency.

T. Meyer, D. Campbell, F. Mackie, 2002, Kidney international.

Urinary levels of substance P and its metabolites are not increased in interstitial cystitis

D. Campbell, A. Rosamilia, P. Dwyer, 2001, BJU international.

Associations of Proinflammatory Cytokines With the Risk of Recurrent Stroke

M. Woodward, G. Lowe, A. Rumley, 2008, Stroke.

Vaccination against high blood pressure.

D. Campbell, 2012, Current pharmaceutical design.

Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease

M. Woodward, A. Jenkins, S. MacMahon, 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

Reduced microvascular density in non-ischemic myocardium of patients with recent non-ST-segment-elevation myocardial infarction.

A. Jenkins, M. Black, D. Campbell, 2013, International journal of cardiology.

Extrarenal renin and blood pressure regulation. An alternative viewpoint.

D. Campbell, 1989, American journal of hypertension.

Can the study of female rats help our understanding of women?

D. Campbell, 2008, HYPERTENSION.

Transthoracic echocardiography findings - implications for clinical management.

H. Krum, D. Campbell, D. Prior, 2012, Australian family physician.

Amino-terminal-pro-B-type natriuretic peptide levels and low diastolic blood pressure: potential relevance to the diastolic J-curve

C. Reid, S. Stewart, R. Wolfe, 2014, Journal of hypertension.

Method of blood collection may explain the suppression of plasma renin concentration in prorenin transgenic mice.

D. Campbell, D. Campbell, 2009, Hypertension.

The vasodilator action of insulin. Implications for the insulin hypothesis of hypertension.

A. Mark, A. Baron, D. Mukherjee, 1993, Hypertension.

Evolving concepts of the renin–angiotensin system. Introduction.

D. Campbell, 2013, Clinical and Experimental Pharmacology and Physiology.

Increased angiotensin-(1-7) in hypophysial-portal plasma of conscious sheep.

D. Campbell, A. Lawrence, I. J. Clark, 1992, Neuroendocrinology.

Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease

A. Jenkins, C. Schalkwijk, M. Black, 2011, Cardiovascular diabetology.

Meeting on AMP-activated

B. Kemp, L. Witters, J. Adams, 2003 .